These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18344431)

  • 1. In vitro evaluation of radioprotective and radiosensitizing effects of rituximab.
    Kapadia NS; Engles JM; Wahl RL
    J Nucl Med; 2008 Apr; 49(4):674-8. PubMed ID: 18344431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an alpha-emitting radioimmunoconjugate and external gamma-irradiation.
    Aurlien E; Kvinnsland Y; Larsen RH; Bruland ØS
    Int J Radiat Biol; 2002 Feb; 78(2):133-42. PubMed ID: 11779363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
    Maddipatla S; Hernandez-Ilizaliturri FJ; Knight J; Czuczman MS
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4556-64. PubMed ID: 17671142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody.
    Kinuya S; Yokoyama K; Kudo M; Kasahara Y; Kobayashi K; Motoishi S; Onoma K; Bunko H; Michigishi T; Tonami N
    J Nucl Med; 2001 Apr; 42(4):596-600. PubMed ID: 11337548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
    Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
    Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab).
    Nishida M; Usuda S; Okabe M; Miyakoda H; Komatsu M; Hanaoka H; Teshigawara K; Niwa O
    Int J Oncol; 2007 Jul; 31(1):29-40. PubMed ID: 17549402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines.
    Takei K; Yamazaki T; Sawada U; Ishizuka H; Aizawa S
    Leuk Res; 2006 May; 30(5):625-31. PubMed ID: 16289746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab.
    Dahle J; Krogh C; Melhus KB; Borrebaek J; Larsen RH; Kvinnsland Y
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):886-95. PubMed ID: 19679402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to rituximab vary among follicular lymphoma B cells of different maturation stages.
    Mattila AM; Meri S
    Scand J Immunol; 2008 Aug; 68(2):159-68. PubMed ID: 18702746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab.
    Carnahan J; Stein R; Qu Z; Hess K; Cesano A; Hansen HJ; Goldenberg DM
    Mol Immunol; 2007 Feb; 44(6):1331-41. PubMed ID: 16814387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole sensitizes breast cancer cells to ionizing radiation.
    Azria D; Larbouret C; Cunat S; Ozsahin M; Gourgou S; Martineau P; Evans DB; Romieu G; Pujol P; Pèlegrin A
    Breast Cancer Res; 2005; 7(1):R156-63. PubMed ID: 15642164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioprotective effect of aloe polysaccharides on three non-tumor cell lines].
    Wang ZW; Huang ZS; Yang AP; Li CY; Huang H; Lin X; Liu ZC; Zhu XF
    Ai Zheng; 2005 Apr; 24(4):438-42. PubMed ID: 15820066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
    Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and radiosensitization effect of TRA-8 on radioresistant human larynx squamous carcinoma cells.
    Wu F; Hu Y; Long J; Zhou YJ; Zhong YH; Liao ZK; Liu SQ; Zhou FX; Zhou YF; Xie CH
    Oncol Rep; 2009 Feb; 21(2):461-5. PubMed ID: 19148523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.
    Cho H; Koto M; Riesterer O; Molkentine DP; Giri U; Milas L; Story MD; Ha CS; Raju U
    Anticancer Res; 2009 Nov; 29(11):4409-15. PubMed ID: 20032386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine.
    Wang H; Wang D; Li M; Zhou C; Ma W; Su X; Liu R; Zhang S
    Cancer Lett; 2008 Sep; 268(1):129-36. PubMed ID: 18468787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioprotection of human endothelial cells with amifostine.
    Andreopoulos D; Schleicher UM; Cotarelo CL; Hand S; Ammon J
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():34-6. PubMed ID: 10584139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
    Khafif A; Hurst R; Kyker K; Fliss DM; Gil Z; Medina JE
    Otolaryngol Head Neck Surg; 2005 Feb; 132(2):317-21. PubMed ID: 15692547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.